Diagnos Laboratorium Utama Tbk. vs Bank Pan Indonesia Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Bank Pan Indonesia Tbk trades at Rp880 (market cap 20.62T, 5.25M 24h volume). The key difference: Bank Pan Indonesia Tbk is far larger — about 66.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank Pan Indonesia Tbk is more actively traded (5.25M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | PNBN | |
|---|---|---|
Market Cap | 310.75B | 20.62T |
Volume | 963.6K | 5.25M |
Lot | 9.64K | 52.51K |
Turnover | 217.67M | 4.62B |
Average Price | 225.89 | 880.1 |
Value | 217.67M | 4.62B |
Indicative Equilibrium Price | 226 | 880 |
Indicative Equilibrium Volume | 1K | 1.91K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Bank Pan Indonesia Tbk (the Bank) was established based on Deed No. 85 dated August 17, 1971 of notary Juliaan Nimrod Siregar gelar Mangaradja, S.H. Panin (Pan Indonesia) Bank was established by the merger of three small private banks. It was one of the first banks to be granted a foreign exchange license in 1972.
Read more on PNBN →